Annual Current Liabilities
$67.66 M
+$11.44 M+20.34%
December 31, 2024
Summary
- As of March 10, 2025, CTKB annual total current liabilities is $67.66 million, with the most recent change of +$11.44 million (+20.34%) on December 31, 2024.
- During the last 3 years, CTKB annual current liabilities has risen by +$34.48 million (+103.92%).
- CTKB annual current liabilities is now at all-time high.
Performance
CTKB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$67.66 M
+$4.87 M+7.75%
December 31, 2024
Summary
- As of March 10, 2025, CTKB quarterly total current liabilities is $67.66 million, with the most recent change of +$4.87 million (+7.75%) on December 31, 2024.
- Over the past year, CTKB quarterly current liabilities has stayed the same.
- CTKB quarterly current liabilities is now at all-time high.
Performance
CTKB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CTKB Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.3% | 0.0% |
| 3 y3 years | +103.9% | +26.3% |
| 5 y5 years | +221.6% | +26.3% |
CTKB Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +103.9% | at high | +103.9% |
| 5 y | 5-year | at high | +221.6% | at high | +155.0% |
| alltime | all time | at high | +221.6% | at high | +155.0% |
Cytek Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $67.66 M(+20.3%) | $67.66 M(+7.7%) |
| Sep 2024 | - | $62.80 M(+19.9%) |
| Jun 2024 | - | $52.38 M(-5.7%) |
| Mar 2024 | - | $55.57 M(-1.2%) |
| Dec 2023 | $56.23 M(+14.7%) | $56.23 M(-4.2%) |
| Sep 2023 | - | $58.69 M(+9.5%) |
| Jun 2023 | - | $53.59 M(-5.2%) |
| Mar 2023 | - | $56.52 M(+15.2%) |
| Dec 2022 | $49.04 M | $49.04 M(+18.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $41.49 M(-2.0%) |
| Jun 2022 | - | $42.35 M(-1.1%) |
| Mar 2022 | - | $42.80 M(+29.0%) |
| Dec 2021 | $33.18 M(+25.0%) | $33.18 M(+10.6%) |
| Sep 2021 | - | $30.01 M(+6.6%) |
| Jun 2021 | - | $28.16 M(+1.4%) |
| Mar 2021 | - | $27.76 M(+4.6%) |
| Dec 2020 | $26.54 M(+26.1%) | $26.54 M |
| Dec 2019 | $21.04 M | - |
FAQ
- What is Cytek Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Cytek Biosciences?
- What is Cytek Biosciences annual current liabilities year-on-year change?
- What is Cytek Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cytek Biosciences?
- What is Cytek Biosciences quarterly current liabilities year-on-year change?
What is Cytek Biosciences annual total current liabilities?
The current annual current liabilities of CTKB is $67.66 M
What is the all time high annual current liabilities for Cytek Biosciences?
Cytek Biosciences all-time high annual total current liabilities is $67.66 M
What is Cytek Biosciences annual current liabilities year-on-year change?
Over the past year, CTKB annual total current liabilities has changed by +$11.44 M (+20.34%)
What is Cytek Biosciences quarterly total current liabilities?
The current quarterly current liabilities of CTKB is $67.66 M
What is the all time high quarterly current liabilities for Cytek Biosciences?
Cytek Biosciences all-time high quarterly total current liabilities is $67.66 M
What is Cytek Biosciences quarterly current liabilities year-on-year change?
Over the past year, CTKB quarterly total current liabilities has changed by $0.00 (0.00%)